Eupraxia Pharmaceuticals, Inc. (EPRX)
7.02
-0.30
(-4.10%)
USD |
NASDAQ |
Oct 13, 10:19
Eupraxia Pharmaceuticals EPS Diluted (Quarterly) : -0.2278 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2278 |
| March 31, 2026 | -0.2333 |
| December 31, 2025 | -0.3337 |
| September 30, 2025 | -0.1898 |
| June 30, 2025 | -0.2613 |
| March 31, 2025 | -0.2069 |
| December 31, 2024 | -0.2107 |
| September 30, 2024 | -0.1668 |
| June 30, 2024 | -0.1686 |
| March 31, 2024 | -0.2097 |
| September 30, 2023 | -0.185 |
| June 30, 2023 | -0.4261 |
| March 31, 2023 | -0.1795 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.301 |
| September 30, 2022 | -0.1879 |
| June 30, 2022 | -0.2397 |
| March 31, 2022 | -0.2046 |
| December 31, 2021 | -0.2071 |
| September 30, 2021 | -0.2772 |
| June 30, 2021 | -0.3346 |
| March 31, 2021 | -0.5439 |
| December 31, 2020 | -0.0082 |
| September 30, 2020 | -0.0896 |
| December 31, 2019 | -0.0433 |
| September 30, 2019 | -0.1027 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Edesa Biotech, Inc. | -0.6003 |
| ProMIS Neurosciences, Inc. | -1.283 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.49M |
| Total Expenses (Quarterly) | 14.49M |
| Enterprise Value | 375.37M |
| Earnings Yield | -14.03% |
| Normalized Earnings Yield | -14.03 |